Search Results - "ROSATO, Roberto R"

Refine Results
  1. 1

    A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations by Reddy, Tejaswini P, Rosato, Roberto R, Li, Xiaoxian, Moulder, Stacy, Piwnica-Worms, Helen, Chang, Jenny C

    Published in Breast cancer research : BCR (04-11-2020)
    “…Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models by Rosato, Roberto R, Dávila-González, Daniel, Choi, Dong Soon, Qian, Wei, Chen, Wen, Kozielski, Anthony J, Wong, Helen, Dave, Bhuvanesh, Chang, Jenny C

    Published in Breast cancer research : BCR (05-09-2018)
    “…Breast cancer has been considered not highly immunogenic, and few patients benefit from current immunotherapies. However, new strategies are aimed at changing…”
    Get full text
    Journal Article
  4. 4

    A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer by Goldstein, Lori J, Perez, Raymond P, Yardley, Denise, Han, Linda K, Reuben, James M, Gao, Hui, McCanna, Susan, Butler, Beth, Ruffini, Pier Adelchi, Liu, Yi, Rosato, Roberto R, Chang, Jenny C

    Published in Breast cancer research : BCR (10-01-2020)
    “…Cancer stem cells (CSCs) are purported to be responsible for tumor initiation, treatment resistance, disease recurrence, and metastasis. CXCR1, one of the…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs by Reddy, Tejaswini P, Choi, Dong S, Anselme, Ann C, Qian, Wei, Chen, Wen, Lantto, Johan, Horak, Ivan D, Kragh, Michael, Chang, Jenny C, Rosato, Roberto R

    Published in Breast cancer research : BCR (15-05-2020)
    “…The human epidermal growth factor receptor (HER) family, notably EGFR, is overexpressed in most triple-negative breast cancer (TNBC) cases and provides cancer…”
    Get full text
    Journal Article
  10. 10

    Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy by Sun, Hongguang, Zhu, Xun, Lu, Patrick Y, Rosato, Roberto R, Tan, Wen, Zu, Youli

    Published in Molecular therapy. Nucleic acids (01-08-2014)
    “…Aptamers are a class of small nucleic acid ligands that are composed of RNA or single-stranded DNA oligonucleotides and have high specificity and affinity for…”
    Get full text
    Journal Article
  11. 11

    TCA cycle-mediated generation of ROS is a key mediator for HeR-MRSA survival under β-lactam antibiotic exposure by Rosato, Roberto R, Fernandez, Regina, Paz, Liliana I, Singh, Christopher R, Rosato, Adriana E

    Published in PloS one (16-06-2014)
    “…Methicillin-resistant Staphylococcus aureus (MRSA) is a major multidrug resistant pathogen responsible for several difficult-to-treat infections in humans…”
    Get full text
    Journal Article
  12. 12

    Staphylococcus pseudintermedius’s PBP4 Is Directly Associated with the Dissociated Oxacillin and Cefoxitin Phenotype by Gagetti, Paula, Rosato, Roberto R., Rosato, Adriana E.

    Published in Antibiotics (Basel) (26-10-2021)
    “…Staphylococcus pseudintermedius is an important pathogen responsible for infections in dogs and in humans. The emergence and dissemination of…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions by Rosato, Roberto R, Almenara, Jorge A, Maggio, Sonia C, Coe, Stefanie, Atadja, Peter, Dent, Paul, Grant, Steven

    Published in Molecular cancer therapeutics (01-10-2008)
    “…The role of reactive oxygen species (ROS) production on DNA damage and potentiation of fludarabine lethality by the histone deacetylase inhibitor (HDACI)…”
    Get full text
    Journal Article
  17. 17

    Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strains by Plata, Konrad B, Riosa, Sarah, Singh, Christopher R, Rosato, Roberto R, Rosato, Adriana E

    Published in PloS one (23-04-2013)
    “…The SOS response, a conserved regulatory network in bacteria that is induced in response to DNA damage, has been shown to be associated with the emergence of…”
    Get full text
    Journal Article
  18. 18

    Exposure of clinical MRSA heterogeneous strains to β-lactams redirects metabolism to optimize energy production through the TCA cycle by Keaton, Mignon A, Rosato, Roberto R, Plata, Konrad B, Singh, Christopher R, Rosato, Adriana E

    Published in PloS one (05-08-2013)
    “…Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as one of the most important pathogens both in health care and community-onset infections. The…”
    Get full text
    Journal Article
  19. 19

    Fate of Mutation Rate Depends on agr Locus Expression during Oxacillin-Mediated Heterogeneous-Homogeneous Selection in Methicillin-Resistant Staphylococcus aureus Clinical Strains by PLATA, Konrad B, ROSATO, Roberto R, ROSATO, Adriana E

    Published in Antimicrobial Agents and Chemotherapy (01-07-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  20. 20